The effect of omega-3 fatty acids on expression of connexin-40 in wistar rat aortaafter lipopolysaccharide administration

Journal of Physiology and Pharmacology

Volumn 65, Issue 1, 2014, Pages 83-94

  Frimmel, K ^a   Vlkovicova, J ^a   Sotnikova, R ^b   Navarova, J ^b   Bernatova, I ^a   Okruhlicova, Ludmila ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Connexin 40; Lipopolysaccharide; Omega 3 fatty acids; Rat aorta; Vascular gap junctions

Indexed keywords

C REACTIVE PROTEIN; CD68 ANTIGEN; CONNEXIN 40; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; N ACETYL BETA GLUCOSAMINIDASE; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AORTA INJURY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; ENZYME ACTIVITY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; LIPID PEROXIDATION; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTA; C-REACTIVE PROTEIN; CONNEXINS; ENDOTHELIAL CELLS; FATTY ACIDS, OMEGA-3; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; VASODILATION;

EID: 84896827686     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009; 11: 267-282.
2. Van Kempen MJ, Jongsma HJ. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 1999; 112: 479-486.
3. Yeh HI, Chang HM, Lu WW, et al. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 2000; 48: 1377-1389.
4. Hill CE, Rummery N, Hickey H, Sandow SL. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clin Exp Pharmacol Physiol 2002; 29: 620-625.
5. Hou CJ, Tsai CH, Yeh HI. Endothelial connexins are downregulated by atherogenic factors. Front Biosci 2008; 13: 3549-3557.
6. Burnier L, Fontana P, Angelillo-Scherrer A, Kwak BR. Intercellular communication in atherosclerosis. Physiology (Bethesda) 2009; 24: 36-44.
7. De Boer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation and infection. J Pathol 2000; 190: 237-243.
8. Al-Bannawi A, Al-Wesebai K, Taha S, Bakhiet M. Chlamydia pneumonia induces chemokine expression by platelets in patients with atherosclerosis. Med Princ Pract 2011; 20: 438-443.
9. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflamatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 2227-2236.
10. Smith BJ, Lightfoot SA, Lerner MR, et al. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol 2000; 18: 1-10.
11. Simon AM, McWhorter AR, Chen HD, Jackson CL, Ouellette Y. Decreased intercellular communication and connexin expression in mouse aortic endothelium during lipopolysaccharide-induced inflammation. J Vasc Res 2004; 41: 323-333.
12. Rignault S, Haefliger JA, Gasser D, et al. Sepsis upregulates the expression of connexin 40 in rat aortic endothelium. Crit Care Med 2005; 33: 1302-1310.
13. Oviedo-Orta E, Errington RJ, Evans WH. Gap junction intercellular communication during lymphocyte transendothelial migration. Cell Biol Int 2002; 26: 253-263.
14. Wong CW, Christen T, Kwak BR. Connexins in leukocytes: shuttling messages? Cardiovasc Res 2004; 62: 357-367.
15. Zahler S, Hoffmann A, Gloe T, Pohl U. Gap junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol 2003; 73: 118-126.
16. Neijssen J, Pang B, Neefjes J. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol 2007; 94: 207-218.
17. Ambrozova G, Pekarova M, Lojek A. Effect of polyunsaturated fatty acids in the reactive oxygen and nitrogen species production by raw 254.7 macrophages. Eur J Nutr 2010; 49: 133-139.
18. Demaison L, Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 2002; 59: 463-477.
19. Luostarinen R, Saldeen T. Dietary fish oil decreases superoxide generation by human neutrophils: relation to cyclooxygenase pathway and lysosomal enzyme release. Prostaglandins Leukot Essent Fatty Acids 1996; 55: 167-172.
20. Das UN. Infection, inflammation, and polyunsaturated fatty acids. Nutrition 2011; 27: 1080-1084.
21. Mezesova L, Jendruchova-Javorkova V, Vlkovicova J, et al. Supplementation with n-3 polyunsaturated fatty acids to lipopolysaccharide-induced rats improved inflammation and functional properties of renal Na, K-ATPase. Nutr Res 2013; 33: 772-779.
22. Vrbjar N, Mezesova L, Javorkova V, et al. Gender specific influence of fish oil or atorvastatin on functional properties of renal Na, K-ATPase in healthy Wistar and hypertriglyceridemic rats. Physiol Res 2011; 60: 887-897.
23. Dlugosova K, Okruhlicova L, Mitasikova M, et al. Modulation of connexin-43 by omega-3 fatty acids in the aorta of old spontaneously hypertensive rats. J Physiol Pharmacol 2009; 60: 63-69.
24. Dlugosova K, Weismann P, Bernatova I, Sotnikova R, Slezak J, Okruhlicova L. Omega-3 fatty acids and atorvastatin affect connexin-43 expression in the aorta of hereditary hypertriglyceridemic rats. Can J Physiol Pharmacol 2009; 87: 1074-1082.
25. Radosinska J, Bacova B, Bernatova I, et al. Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats. Mol Cell Biochem 2011; 347: 163-173.
26. Bacova B, Radosinska J, Knezl V, et al. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, conexin-43. J Physiol Pharmacol 2010; 61: 717-723.
27. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997; 43: 1209-1214.
28. Kramer JH, Murthi SB, Wise RM, Mak IT, Weglicki WB. Antioxidant and lysosomotropic properties of acute Dpropranolol underlies its cardioprotection of postischemic hearts from moderate iron-overloaded rats. Exp Biol Med (Maywood) 2006; 231: 473-484.
29. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186: 421-431.
30. Navarova J, Nosalova V. Effect of H2-receptor antagonists on indomethacin-induced lysosomal enzyme release from rat gastric mucosa. Methods Find Exp Clin Pharmacol 1994; 16: 119-124.
31. Sotnikova R, Okruhlicova L, Noskovic P. Endothelial protective effect of stobadine on ischemia/reperfusioninduced injury. Gen Physiol Biophys 1998; 17: 253-264.
32. Bernatova I, Pechanova O, Babal P, et al. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol 2002; 282: H942-H948.
33. Sotnikova R, Okruhlicova L, Navarova J, et al. Toxic effect of hyperglycemia on rat aortic function and structure. Effect of L-arginine. Biologia 2005; 5: 107-111.
34. Schmidt C, Hocherl K, Schweda F, Kurtz A, Bucher M. Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 2007; 18: 1072-1083.
35. Morris M, Li L. Molecular mechanisms and pathological consequences of endotoxin tolerance and priming. Arch Immunol Ther Exp (Warsz) 2012; 60: 13-18.
36. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2013; Oct 22 (epub ahead of print).
37. Lum H, Roebuck KA. Oxidant stress and endothelial dysfunction. Am J Physiol Cell Physiol 2001; 280: C719-C741.
38. Kang WS, Tamarkin FJ, Wheeler MA, Weiss RM. Rapid upregulation of endothelial nitric-oxide synthase in a mouse model of Escherichia coli lipopolysaccharide-induced bladder inflammation. J Pharmacol Exp Ther 2004; 310: 452-458.
39. Muller B, Kleschyov AL, Gyorgy K, Stoclet JC. Inducible NO synthase activity in blood vessels and heart: new insight into cell origin and consequences. Physiol Res 2000; 49: 19-26.
40. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 2003; 17: 773-775.
41. Bauer V, Sotnikova R, Drabikova K. Effects of activated neutrophils on isolated rings of rat thoracic aorta. J Physiol Pharmacol 2011; 62: 513-520.
42. Michel O, Dentener M, Corazza F, Buurman W, Rylander R. Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol 2001; 107: 797-804.
43. Zollbrecht C, Grassl M, Fenk S, et al. Expression pattern in human macrophages dependent on 9p21.3 coronary artery disease risk locus. Atherosclerosis 2013; 227: 244-249.
44. Fries S, Grosser T, Price TS, et al. Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2. Gastroenterology 2006; 130: 55-64.
45. Ramachandran S, Xie LH, John SA, Subramaniam S, Lal R. A novel role for connexin hemichannel in oxidative stress and smoking-induced cell injury. PLoS One 2007; 8: e712.
46. De Vuyst E, Decrock E, De Bock M, et al. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 2007; 18: 34-46.
47. Klaunig JE, Ruch RJ. Strain and species effects on the inhibition of hepatocytes intercellular communication by liver tumor promoters. Cancer Lett 1987; 36: 161-168.
48. Haefliger JA, Meda P. Chronic hypertension alters the expression of Cx43 in cardiovascular muscle cells. Braz J Med Biol Res 2000; 33: 431-438.
49. Simon AM, McWhorter AR, Chen H, Jackson CL, Ouellette Y. Decreased intercellular communication and expression in mouse aortic endothelium during lipopolysaccharideinduced inflammation. J Vasc Res 2004; 41: 323-333.
50. Bolon ML, Kidder GM, Simon AM, Tyml K. Lipopolysaccharide reduces electrical coupling in microvascular endothelial cells by targeting connexin40 in tyrosine-, ERK1/2-, PKA-, and PKC-dependent manner. J Cell Physiol 2007; 21: 159-166.
51. Van Rijen HV, Van Kempen MJ, Postma S, Jongsma HJ. Tumor necrosis factor alpha alters the expression of connexin43, connexin40 and connexin37 in human umbilical vein endothelial cells. Cytokine 1998; 10: 258-264.
52. Rignault S, Haefliger JA, Waeber B, Liaudet L, Feihl F. Acute inflammation decreases the expression of connexin40 in mouse lung. Shock 2007; 28: 78-85.
53. Wang LH, Chen JZ, Sun YL, et al. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol 2005; 100: 467-475.
54. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerosis plaque. Arterioscler Thromb Vasc Biol 2002; 22: 225-230.
55. Abbasian M, Sayyah M, Babapur V, Mahdian R, Choopani S, Kaviani B. Upregulation of connexin30 and 32 gap junctions in rat hippocampus at transcription level by chronic ventral injection of lipopolysaccharide. Iran Biomed J 2012; 16: 127-132.
56. Sayyah M, Kaviani B, Khoshkholgh-Sima B, et al. Effect of chronic intracerebroventricular administration of lipopolysaccharide on connexin43 protein expression in rat hippocampus. Iran Biomed J 2012; 16: 25-32.
57. Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. Interferon gamma, a mediator of lethal lipopolysaccharideinduced Schwartzman-like shock reactions in mice. J Exp Med 1990; 171: 1853-1869.
58. Bruzzone S, Guida L, Zocchi E, Franco L, De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J 2001; 15: 10-12.
59. Hu J, Cotgreave IA. Differential regulation of gap junctions by proinflammatory mediators in vitro. J Clin Invest 1997; 99: 2312-2316.
60. Looft-Wilson RC, Billaud M, Johnstone SR, Straub AC, Isakson BE. Interaction between nitric oxide signaling and gap junctions: effects on vascular function. Biochim Biophys Acta 2012; 1818: 1895-1902.
61. Kameritsch P, Hoffmann A, Pohl U. Opposite effects of nitric oxide on different connexins expressed in the vascular system. Cell Commun Adhes 2003; 10: 305-309.
62. Alonso F, Boittin FX, Beny JL, Haefliger JA. Loss of connexin40 is associated with decreased endotheliumdependent relaxation and eNOS levels in the mouse aorta. Am J Physiol Heart Circ Physiol 2010; 299: H1365-H1373.
63. Hoffmann A, Gloe T, Pohl U, Zahler S. Nitric oxide enhances de novo formation of endothelial gap junctions. Cardiovasc Res 2003; 60: 421-430.
64. Kralova Lesna I, Suchanek P, Brabcova E, Kovar J, Malinska H, Poledne R. Effect of different types of dietary fatty acids on subclinical inflammation in humans. Physiol Res 2013; 62: 145-152.
65. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 12-24.
66. Tong J, Briggs MM, Mlaver D, Vidal A, McIntosh TJ. Sorting of lens aquaporins and connexins into raft and nonraft bilayers: role of protein in homo-oligomerization. Biophys J 2009; 97: 2493-2502.
67. Di Nunzio M, Valli V, Bordoni A. Pro-and anti-oxidant effects of polyunsaturated fatty acid supplementation in HepG2 cells. Prostaglandins Leukot Ess Fatty Acids 2011; 85: 121-127.
68. Serini S, Fasano E, Piccioni E, Cittadini AR, Calviello G. Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects. Chem Res Toxicol 2011; 24: 2093-20103.
69. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61: 345-358.
70. Esterbauer H. Cytotoxicity and genotoxicity of lipid oxidation products. Am J Clin Nutr 1993; 57 (Suppl. 5): 779-785.
71. Halvorsen BL, Blomhoff R. Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements. Food Nutr Res 2011; 55: doi: 10.3402/fnr.v55i0.5792
72. Awada M, Soulage CO, Meynier A, et al. Dietary oxidized n-3 PUFA induce oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J Lipid Res 2012; 53: 2069-2080.
73. de Lima TM, de Sa Lima L, Scavone C, Curi R. Fatty acids control of nitric oxide production by macrophages. FEBS Lett 2006; 580: 3287-3295.
74. Mullen A, Loscher CE, Roche HM. Anti-inflammatory effects of EPA and DHA are dependent upon time and doseresponse elements associated with LPS stimulation in THP-1-derived macrophages. J Nutr Biochem 2010; 21: 444-450.
75. Gourdin MJ, Ponchau O, Jamart J, De Kock M. Ageing influences the effect of pre-hypoxic administration of clonidine, an alpha2-adrenoceptor agonist, on post-hypoxic vasomotricity. J Physiol Pharmacol 2012; 63: 165-171.
76. Sotnikova R, Okruhlicova L, Dlugosova K, et al. Effect of n-3 PUFA on endothelium-dependent relaxation of the superior mesenteric artery. In: Proceedings of Experimental Approaches in Basic Research and Diagnostic of Diseases: Tailoring the Treatment. Tribulova N, Okruhlicova L, Slezak J. (eds.) VEDA Bratislava 2008, pp.127-134.
77. Zhang R, Ran HH, Zhang YX, et al. Farnesoid X receptor regulates vascular reactivity through nitric oxide mechanism. J Physiol Pharmacol 2012; 63: 367-372.